Marksans Pharma Limited (MARKSANS)
₹247.2
INR-2.95(-1.18%)
As of June 19, 2025 9:45:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹11689.37 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹11317.60 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
30.71
Forward P/E
Price to Earnings ratio based on forecasted earnings
18.30
PEG Ratio
Price/Earnings to Growth ratio
NA
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
4.46
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
54.09%
Operating Margin
Operating income as a percentage of revenue
14.54%
Return on Equity
Net income as a percentage of shareholders' equity
16.73%
Revenue (TTM)
Total revenue over trailing 12 months
₹2622.84 Cr+26.5%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹599.01 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹8.40+15.7%
Balance Sheet
Total Cash
Total cash and short-term investments
₹704.95 Cr
Total Debt
Total short-term and long-term debt
₹321.91 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
12.93%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹157.06 - ₹358.7
Beta
Measure of stock's volatility compared to the market
1.38
Shares Outstanding
Total number of shares issued by the company
₹45.32 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
82.12%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
20.53%
Payout Ratio
Percentage of earnings paid as dividends
7.14%
